| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0045 | 1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |